Regulation of NMDA receptor trafficking by amyloid-β
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-beta reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-beta promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-beta by treating neurons with a gamma-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-beta application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-beta-dependent endocytosis of NMDA receptors required the alpha-7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-beta can cause synaptic dysfunction and contribute to Alzheimer disease pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This synaptotoxicity is associated with a reduction in the surface expression of various receptor proteins, including those forming the N-methyl-D-aspartate receptors [26,27], which are critical for generation of long-term potentiation in hippocampal synapses.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“Oligomeric Aβ species have been shown to cause memory deficits in rodents [25] and are known for their synaptotoxic properties.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“It has been previously reported that extracellular application of Ab oligomers to primary neuronal cultures or organotypic hippocampal slices induce rapid changes in the structure and density of synaptic spines 47,48 and reduces expression of NMDARs and related synaptic proteins, 49 through several signaling pathways, one of which involves the a-7 nicotinic receptor.49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“These cultures are characterized by progressive buildup of intraneuronal Ab, which is derived from endogenous Ab escaping exocytosis after cleavage of the APP SW mutant.9,49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“Indeed Aβ production and amyloid production has been shown to reduce cell surface levels of other proteins including the NMDA receptor and the EphB2 receptor, both involved in synaptic plasticity [57], [58].”
From LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease (2010) · cites this paper as [57]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Results Amyloid-β decreases surface expression of NMDA receptors Low amounts of secreted soluble amyloid-β regulate glutamatergic currents mediated by both NMDA and AMPA receptors without affecting GABA receptor current”
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting
Ehlers, M. D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00129-x · Cited by 1,096
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
Cited by
Items 301–400 of 1,006
Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer’s disease
Ma, T., & Klann, E. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07506.x · Cited by 132
“Ab has been shown to interfere with normal NMDAR trafficking by triggering receptor internalization, thus reducing the number of surface NMDARs (Snyder et al. 2005).”
New developments on the role of NMDA receptors in Alzheimer's disease
Malinow, R. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.09.001 · Cited by 132
Hinrich, A. J., Jodelka, F. M., Chang, J. L., Brutman, D., Bruno, A. M., Briggs, C. A., James, B. D., Stutzmann, G. E., Bennett, D. A., Miller, S. A., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505846 · Cited by 127
“Reelin signaling, potentially through ApoER2, has been shown to counteract this Ab toxicity (Kamenetz et al, 2003; Snyder et al, 2005; Durakoglugil et al, 2009).”
InfluentialMiller, E. C., Teravskis, P. J., Dummer, B. W., Zhao, X., Huganir, R. L., & Liao, D. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12507 · Cited by 131
“…a number of research groups have reported the necessity of calcineurin in cognitive and synaptic deficits found in AD models (Chen et al., 2002; Snyder et al., 2005; Dineley et al., 2007; Abdul et al., 2009; Wu et al., 2010), the role of calcineurin in synaptic deficits caused by extracellular…”
Ting, J. T., Kelley, B. G., Lambert, T. J., Cook, D. G., & Sullivan, J. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608807104 · Cited by 114
Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins
Reid, P. C., Urano, Y., Kodama, T., & Hamakubo, T. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00054.x · Cited by 131
“Recent evidence suggests that the oligomeric form of these A peptides may be the key form responsible for the cognitive problems of people with AD [5, 6].”
Emerging topics in Reelin function
Förster, E., Bock, H. H., Herz, J., Chai, X., Frotscher, M., & Zhao, S. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07222.x · Cited by 130
“Incubation of hippocampal neurons with Aβ-oligomers impaired endocytosis and trafficking of AMPA- and NMDA-receptors and thus decreased LTP (Hsieh et al., 2006; Kamenetz et al., 2003; Snyder et al., 2005).”
Pascoli, V., Besnard, A., Hervé, D., Pagès, C., Heck, N., Girault, J., Caboche, J., & Vanhoutte, P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.031 · Cited by 148
p21-activated Kinase-aberrant Activation and Translocation in Alzheimer Disease Pathogenesis
Ma, Q.-L., Yang, F., Calon, F., Ubeda, O. J., Hansen, J. E., Weisbart, R. H., Beech, W., Frautschy, S. A., & Cole, G. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708034200 · Cited by 128
Prox, J., Bernreuther, C., Altmeppen, H., Grendel, J., Glatzel, M., D'Hooge, R., Stroobants, S., Ahmed, T., Balschun, D., Willem, M., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5910-12.2013 · Cited by 129
“The A inhibitory effects on synaptic plasticity may also occur through promotion of NMDAR endocytosis and an associated depression of NMDA-evoked currents (Snyder et al., 2005).”
Savioz, A., Leuba, G., & Vallet, P. G. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.09.004 · Cited by 130
Synaptic plasticity: one STEP at a time
Braithwaite, S. P., Paul, S., Nairn, A. C., & Lombroso, P. J. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.06.007 · Cited by 138
“STEP regulates NMDA receptor trafficking by controlling the level of tyrosine phosphorylation of the NR2B subunit [ 45 ].”
BackgroundSelf-citationLeptin regulation of hippocampal synaptic function in health and disease
Irving, A. J., & Harvey, J. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0155 · Cited by 129
Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3
Reinders, N. R., Pao, Y., Renner, M. C., da Silva-Matos, C. M., Lodder, T. R., Malinow, R., & Kessels, H. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614249113 · Cited by 128
“Aβ oligomers trigger an NMDAR-dependent signaling pathway that leads to synaptic depression through the removal of AMPA receptors (AMPARs) and NMDARs from synapses (7, 11, 14).”
Mammalian Reverse Genetics without Crossing Reveals Nr3a as a Short-Sleeper Gene
Sunagawa, G. A., Sumiyama, K., Ukai-Tadenuma, M., Perrin, D., Fujishima, H., Ukai, H., Nishimura, O., Shi, S., Ohno, R.-I., Narumi, R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.052 · Cited by 128
“…the NMDAR is implicated in several psychological disorders, including schizophrenia (Belforte et al., 2010; Moghaddam and Javitt, 2012; Mohn et al., 1999), Alzheimer’s disease (Snyder et al., 2005), and depression (Autry et al., 2011; Li et al., 2010), all of which have associated sleep disorders.”
Tampellini, D., Rahman, N., Gallo, E. F., Huang, Z., Dumont, M., Capetillo-Zarate, E., Ma, T., Zheng, R., Lu, B., Nanus, D. M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2292-09.2009 · Cited by 127
“We confirmed the latter also in our experimental model by adding 1 M A 1-42 to wild-type cultured neurons as previously described (Almeida et al., 2005; Snyder et al., 2005), which revealed a 51 10% increase in levels of intraneuronal A 42 immunofluorescence in dendrites in treated compared with untreated neurons (Fig.”
InfluentialSelf-citationLipoprotein receptors – an evolutionarily ancient multifunctional receptor family
Dieckmann, M., Dietrich, M. F., & Herz, J. (2010) · Biological Chemistry · doi:10.1515/bc.2010.129 · Cited by 127
“…effect on anti-angiogenic activity of thrombospondin-2 would suggest a role in the control of local tumor growth (Boucher et al., 2003; Zhou et al., 2009); by contrast, LRP1-mediated activation of metalloproteases 2 and 9 was shown to promote cancer cell migration and invasion (Song et al., 2009).”
DaRocha-Souto, B., Scotton, T. C., Coma, M., Serrano-Pozo, A., Hashimoto, T., Serenó, L., Rodríguez, M., Sánchez, B., Hyman, B. T., & Gómez-Isla, T. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318217a118 · Cited by 126
Espana, J., Valero, J., Minano-Molina, A. J., Masgrau, R., Martin, E., Guardia-Laguarta, C., Lleo, A., Gimenez-Llort, L., Rodriguez-Alvarez, J., & Saura, C. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2154-10.2010 · Cited by 127
“Because A depresses excitatory synaptic transmission through AMPA and NMDA receptors (Snyder et al., 2005; Hsieh et al., 2006; Dewachter et al., 2009), one possibility is that A modulates differentially glutamatergic signaling depending on its levels (Puzzo et al., 2008).”
BackgroundResultInfluentialDivino da Rocha, M., Pereira Dias Viegas, F., Cristina Campos, H., Carolina Nicastro, P., Calve Fossaluzza, P., Alberto Manssour Fraga, C., J. Barreiro, E., & Viegas, C. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711794480429 · Cited by 126
Findley, C. A., Bartke, A., Hascup, K. N., & Hascup, E. R. (2019) · ASN Neuro · doi:10.1177/1759091419855541 · Cited by 125
Bioactive Polyphenols and Neuromodulation: Molecular Mechanisms in Neurodegeneration
Meo, F. D., Valentino, A., Petillo, O., Peluso, G., Filosa, S., & Crispi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072564 · Cited by 141
Effects of Stress and Stress Hormones on Amyloid-β Protein and Plaque Deposition
Dong, H., & Csernansky, J. G. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1152 · Cited by 125
“Aβ formation and neurotoxicity [100–103].”
Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction
Kakuda, T. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.03.010 · Cited by 124
The putative neurodegenerative links between depression and Alzheimer's disease
Wuwongse, S., Chang, R. C., & Law, A. C. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.005 · Cited by 133
“Activation of Nmethyl-D-aspartic acid (NMDA) receptors has been implicated in Ab-mediated excitatory neurodegeneration and NMDA receptor antagonists could be neuroprotective (Parsons et al., 2007; Snyder et al., 2005).”
Calabrese, B., Shaked, G. M., Tabarean, I. V., Braga, J., Koo, E. H., & Halpain, S. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.02.006 · Cited by 114
Shen, H., Kihara, T., Hongo, H., Wu, X., Kem, W., Shimohama, S., Akaike, A., Niidome, T., & Sugimoto, H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00894.x · Cited by 120
“Recent evidence has suggested that beta amyloid (Ab), a major component of senile plaques found in the brains of AD patients, leads to the internalization of NMDA receptors and subsequently reduces glutamatergic transmission and inhibits synaptic plasticity (Snyder et al., 2005).”
InfluentialNMDA Receptor Function During Senescence: Implication on Cognitive Performance
Kumar, A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00473 · Cited by 121
“Finally, increased phosphatase activity has been linked to the internalization of NMDA receptors (Snyder et al., 2005).”
Ripoli, C., Cocco, S., Li Puma, D. D., Piacentini, R., Mastrodonato, A., Scala, F., Puzzo, D., D'Ascenzo, M., & Grassi, C. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1201-14.2014 · Cited by 122
“A was also suggested to trigger NMDA receptor internalization following nAChR activation (Snyder et al., 2005).”
Sorting receptor SORLA – a trafficking path to avoid Alzheimer disease
Willnow, T. E., & Andersen, O. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.125393 · Cited by 121
“Oligomeric forms of Ab impair synaptic plasticity by inducing the internalization of glutamate receptors from the synaptic plasma membrane (Snyder et al., 2005; Hsieh et al., 2006).”
Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A antibody
Bales, K. R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27120 · Cited by 120
On the Hypes and Falls in Neuroprotection: Targeting the NMDA Receptor
Villmann, C., & Becker, C. (2007) · The Neuroscientist · doi:10.1177/1073858406296259 · Cited by 135
Wnt-5aoccludes Aβ oligomer-induced depression of glutamatergic transmission in hippocampal neurons
Cerpa, W., Farías, G. G., Godoy, J. A., Fuenzalida, M., Bonansco, C., & Inestrosa, N. C. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-3 · Cited by 119
“These findings suggest that Ab oligomers promote the endocytosis of NMDA and AMPA channels, as it has been reported in hippocampal [31] and cortical neurons [25].”
InfluentialGardoni, F., & Bellone, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00025 · Cited by 118
“At the same time, the activation of this pathway promotes the phosphorylation of both AMPARs and NMDARs providing a mechanism for the direct control of glutamatergic transmission by DA signaling (Snyder et al., 1998, 2005).”
Viviani, B., Gardoni, F., Bartesaghi, S., Corsini, E., Facchi, A., Galli, C. L., Di Luca, M., & Marinovich, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602156200 · Cited by 110
Oligomeric Aβ in the monkey brain impacts synaptic integrity and induces accelerated cortical aging
Beckman, D., Ott, S., Donis-Cox, K., Janssen, W. G., Bliss-Moreau, E., Rudebeck, P. H., Baxter, M. G., & Morrison, J. H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902301116 · Cited by 111
The Interplay between Ca2+ Signaling Pathways and Neurodegeneration
Ureshino, R. P., Erustes, A. G., Bassani, T. B., Wachilewski, P., Guarache, G. C., Nascimento, A. C., Costa, A. J., Smaili, S. S., & da Silva Pereira, G. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236004 · Cited by 117
“Together, these results represent potential Aβ-mediated mechanisms for the inhibition of glutamatergic transmission and synaptic plasticity [39].”
BackgroundKnobloch, M., Farinelli, M., Konietzko, U., Nitsch, R. M., & Mansuy, I. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0395-07.2007 · Cited by 117
“To investigate whether other major signaling pathways downstream of the NMDA receptor are implicated in the mechanisms of A toxicity in vivo, we generated a transgenic mouse model expressing a human amyloid precursor protein (APP) with the Swedish and Arctic mutations (arcA mice) that produces a form of A more prone t…”
InfluentialAge and Alzheimer’s disease gene expression profiles reversed by the glutamate modulator riluzole
Pereira, A. C., Gray, J. D., Kogan, J. F., Davidson, R. L., Rubin, T. G., Okamoto, M., Morrison, J. H., & McEwen, B. S. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.33 · Cited by 116
Williams, C., Mehrian Shai, R., Wu, Y., Hsu, Y.-H., Sitzer, T., Spann, B., McCleary, C., Mo, Y., & Miller, C. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004936 · Cited by 116
PSD-95 stabilizes NMDA receptors by inducing the degradation of STEP 61
Won, S., Incontro, S., Nicoll, R. A., & Roche, K. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609702113 · Cited by 142
“Previous studies have demonstrated that dysregulation of NMDAR trafficking is associated with Alzheimer’s disease (19, 40), and NMDAR hypofunction is implicated in schizophrenia in humans and animal models (16, 19, 41).”
Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα
Mockett, B. G., Richter, M., Abraham, W. C., & Müller, U. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00030 · Cited by 115
“…Aβ levels may in part relate to altered transmission and loss of dendritic spines (reviewed by SpiresJones and Knafo, 2012), as well as impairments in N-methylD-aspartate (NMDA) receptor expression and inhibition of LTP-associated de novo protein synthesis (Snyder et al., 2005; Li et al., 2011).”
BackgroundThe Role of microRNAs in Alzheimer’s Disease and Their Therapeutic Potentials
Miya Shaik, M., Tamargo, I., Abubakar, M., Kamal, M., Greig, N., & Gan, S. (2018) · Genes · doi:10.3390/genes9040174 · Cited by 115
“For example, Aβ has been shown to induce endocytosis of N-methyl-D-aspartate receptors (NMDArs), which are key receptors involved in synaptic plasticity and memory function [59], in the postsynaptic membranes of cortical neurons [60].”
BackgroundSynaptic tau: A pathological or physiological phenomenon?
Robbins, M., Clayton, E., & Kaminski Schierle, G. S. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01246-y · Cited by 116
Bürklen, T. S., Schlattner, U., Homayouni, R., Gough, K., Rak, M., Szeghalmi, A., & Wallimann, T. (2006) · BioMed Research International · doi:10.1155/jbb/2006/35936 · Cited by 116
“Very recent data by Snyder et al show that Aβ addition to cortical neurons in cell cultures leads to internalization of NMDA-receptors with concomitant dephosphorylation of the NMDA receptor subunit NR2B at Tyr 1472 [123].”
Freudenberg, F., Alttoa, A., & Reif, A. (2015) · Genes, Brain and Behavior · doi:10.1111/gbb.12193 · Cited by 115
“This might be further aggravated by 𝛽-amyloid induced downregulation of the NO/cGMP/cGK/CREB pathway (Puzzo et al. 2005) or endocytosis of the NMDA receptor, mediated by dissociation of PSD-95, thus disrupting the NMDA/PSD-95/NOS-I/sGC protein complex (Snyder et al. 2005).”
Russell, C. L., Semerdjieva, S., Empson, R. M., Austen, B. M., Beesley, P. W., & Alifragis, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043201 · Cited by 115
“[10,25,26,27].”
Stys, P. K., You, H., & Zamponi, G. W. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.225276 · Cited by 115
Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease
Penzes, P., & VanLeeuwen, J.-E. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.01.003 · Cited by 114
The Effects of Amyloid Precursor Protein on Postsynaptic Composition and Activity
Hoe, H.-S., Fu, Z., Makarova, A., Lee, J.-Y., Lu, C., Feng, L., Pajoohesh-Ganji, A., Matsuoka, Y., Hyman, B. T., Ehlers, M. D., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900141200 · Cited by 115
The dendritic hypothesis for Alzheimer's disease pathophysiology
Cochran, J. N., Hall, A. M., & Roberson, E. D. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.12.004 · Cited by 114
“This potentiation causes an increase in calcium influx through NMDA receptors and α7nACh receptors [127, 177], which can then activate several signaling cascades, including calcineurin/calpain and Fyn kinase, which work in concert to cause excitation-inhibition imbalance and dendritic abnormalities.”
BackgroundInfluentialAmyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease
Um, J. W., & Strittmatter, S. M. (2013) · Prion · doi:10.4161/pri.22212 · Cited by 114
β-Amyloid Modulation of Synaptic Transmission and Plasticity
Venkitaramani, D. V., Chin, J., Netzer, W. J., Gouras, G. K., Lesne, S., Malinow, R., & Lombroso, P. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3478-07.2007 · Cited by 114
“…neuronal survival (Lambert et al., 1998; Kayed et al., 2003), inhibition of LTP (Walsh et al., 2002), disruption of behavior (Cleary et al., 2005), and endocytosis of NMDA receptors (Snyder et al., 2005), those of endogenous soluble A assemblies have only recently been studied (Lesne et al., 2006).”
InfluentialSelf-citationMolecular Consequences of the ACVR1R206H Mutation of Fibrodysplasia Ossificans Progressiva
Song, G.-A., Kim, H., Woo, K. M., Baek, J., Kim, G.-S., Choi, J., & Ryoo, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094557 · Cited by 116
Cleavage Agents for Soluble Oligomers of Amyloid β Peptides
Suh, J., Yoo, S. H., Kim, M. G., Jeong, K., Ahn, J. Y., Kim, M., Chae, P. S., Lee, T. Y., Lee, J., Lee, J., et al. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200702399 · Cited by 114
Agosta, F., Dalla Libera, D., Spinelli, E. G., Finardi, A., Canu, E., Bergami, A., Bocchio Chiavetto, L., Baronio, M., Comi, G., Martino, G., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24235 · Cited by 113
Koronyo‐Hamaoui, M., Ko, M. K., Koronyo, Y., Azoulay, D., Seksenyan, A., Kunis, G., Pham, M., Bakhsheshian, J., Rogeri, P., Black, K. L., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06402.x · Cited by 113
Amyloid β and APP as biomarkers for Alzheimer’s disease
Zetterberg, H., Blennow, K., & Hanse, E. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.08.002 · Cited by 136
“There have been mixed results regarding the extent to which AMPA and/or NMDA receptors are removed from the synapse (Chang et al., 2006; Kamenetz et al., 2003; Snyder et al., 2005; Ting et al., 2007).”
Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases
Forloni, G., Artuso, V., La Vitola, P., & Balducci, C. (2016) · Movement Disorders · doi:10.1002/mds.26624 · Cited by 113
“The internalization of NMDA receptors induced by Ab oligomers was associated with the activation of a7nAchChR.(65) Successively, the activation of extrasynaptic N-methyl D-aspartate receptor subtype 2B (NR2B)containing receptors was described for the inhibition of LTP induced by Ab oligomers.”
Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model
Goebel‐Goody, S. M., Wilson‐Wallis, E. D., Royston, S., Tagliatela, S. M., Naegele, J. R., & Lombroso, P. J. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2012.00781.x · Cited by 108
“…and Behavior © 2012 Blackwell Publishing Ltd and International Behavioural and Neural Genetics Society strengthening by promoting NMDAR internalization and inactivating ERK1/2, Fyn and Pyk2 (Nguyen et al. 2002; Pelkey et al. 2002; Paul et al. 2003; Snyder et al. 2005; Venkitaramani et al. 2011).”
BackgroundSelf-citationAltered synaptic function in Alzheimer's disease
Bell, K. F. S., & Cuello, A. C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.045 · Cited by 135
“This amyloid beta protein-induced diminution in cell surface NMDA receptor levels was found to be dependent on the alpha-seven nicotinic receptor and furthermore was also found to inhibit CREB phosphorylation, a required step for long term potentiation (LTP)-related gene transcription (Snyder et al., 2005).”
BackgroundInfluentialOriglia, N., Bonadonna, C., Rosellini, A., Leznik, E., Arancio, O., Yan, S. S., & Domenici, L. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2127-10.2010 · Cited by 111
“…LTP (Origlia et al., 2008, 2009) depressed synaptic transmission and impaired a second form of long-term synaptic plasticity, namely the LTD, by increasing the synaptic removal of glutamate receptors (Snyder et al., 2005; Tyszkiewicz and Yan, 2005; Hsieh et al., 2006; Parameshwaran et al., 2007).”
InfluentialSimón, A. M., de Maturana, R. L., Ricobaraza, A., Escribano, L., Schiapparelli, L., Cuadrado-Tejedor, M., Pérez-Mediavilla, A., Avila, J., Del Río, J., & Frechilla, D. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1096 · Cited by 111
“Indeed, some reports have shown alterations in AMPA and NMDA receptors in postsynaptic hippocampal membranes of brains from both AD patients [24] and cultured neurons of AβPP transgenic mice [25,26].”
APP Receptor? To Be or Not To Be
Deyts, C., Thinakaran, G., & Parent, A. T. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.01.005 · Cited by 112
Amyloid-β-Induced Dysregulation of AMPA Receptor Trafficking
Guntupalli, S., Widagdo, J., & Anggono, V. (2016) · Neural Plasticity · doi:10.1155/2016/3204519 · Cited by 110
Costa, R. O., Lacor, P. N., Ferreira, I. L., Resende, R., Auberson, Y. P., Klein, W. L., Oliveira, C. R., Rego, A. C., & Pereira, C. M. F. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00848.x · Cited by 110
“subcellular localization of NMDAR subunits, namely of GluN1 (Snyder et al., 2005; Lacor et al., 2007).”
InfluentialADDLs and the signaling web that leads to Alzheimer’s disease
Krafft, G. A., & Klein, W. L. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.012 · Cited by 122
“Antagonists of NMDA and ACh receptors attenuate these structural regressions (De Felice et al., 2007b; Hsieh et al., 2006; Lacor et al., 2007; Shankar et al., 2007; Snyder et al., 2005), but some alterations remain.”
InfluentialDeregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice
Dewachter, I., Filipkowski, R. K., Priller, C., Ris, L., Neyton, J., Croes, S., Terwel, D., Gysemans, M., Devijver, H., Borghgraef, P., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.011 · Cited by 122
The Essential Role of Soluble Aβ Oligomers in Alzheimer’s Disease
Wang, Z.-X., Tan, L., Liu, J., & Yu, J.-T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9143-0 · Cited by 110
“This internalization of NMDAR requires the activation of α7nAchR [73].”
Liu, Q., Zhang, J., Zhu, H., Qin, C., Chen, Q., & Zhao, B. (2006) · The FASEB Journal · doi:10.1096/fj.06-5841com · Cited by 119
Nicotinic receptors, allosteric proteins and medicine
Changeux, J., & Taly, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.01.001 · Cited by 115
Cole, G. M., & Frautschy, S. A. (2006) · Nutrition and Health · doi:10.1177/026010600601800307 · Cited by 110
“, 2004) and lead to NMDA receptor subunit endocytosis (Snyder et al., 2005).”
Synaptic targeting by Aβ oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease
Klein, W. L. (2006) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.11.003 · Cited by 110
“[41] Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, et al.”
Rozkalne, A., Hyman, B. T., & Spires-Jones, T. L. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.11.014 · Cited by 103
Delineating the Mechanism of Alzheimer’s Disease Aβ Peptide Neurotoxicity
Cappai, R., & Barnham, K. J. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9469-8 · Cited by 108
“This is consistent with cell derived Ab oligomers altering the transport of the NMDA receptor by promoting its endocytosis and resulting in decreased NMDA receptor activity both in vitro and in APP transgenic mice [34].”
Synaptic Dysfunction in Alzheimer’s Disease
Marcello, E. E., Epis, R., Saraceno, C., & Luca, M. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_25 · Cited by 125
“Although the mechanisms underlying Ab-induced LTD have not yet been fully elucidated, they may involve receptor internalization (Snyder et al. 2005; Hsieh et al. 2006) or desensitization (Liu et al.”
BackgroundInfluentialSrc family kinases: modulators of neurotransmitter receptor function and behavior
Ohnishi, H., Murata, Y., Okazawa, H., & Matozaki, T. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.09.005 · Cited by 118
Protein Phosphatases and Alzheimer's Disease
Braithwaite, S. P., Stock, J. B., Lombroso, P. J., & Nairn, A. C. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-396456-4.00012-2 · Cited by 107
“M echanisms of Action of Protein Phosphatase 2B in Mediating the Effects of Ab.”
InfluentialSelf-citationZádori, D., Veres, G., Szalárdy, L., Klivényi, P., & Vécsei, L. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170929 · Cited by 107
Radiation Induces Acute Alterations in Neuronal Function
Wu, P. H., Coultrap, S. J., Pinnix, C. C., Davies, K. D., Tailor, R. C., Ang, K. K., Browning, M. D., & Grosshans, D. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037677 · Cited by 119
“Conversely, tyrosine phosphatase-dependent NMDAR endocytosis may play a role in neuronal dysfunction induced by amyloid beta exposure [17].”
Neuronal Network Oscillations in Neurodegenerative Diseases
Nimmrich, V., Draguhn, A., & Axmacher, N. (2015) · NeuroMolecular Medicine · doi:10.1007/s12017-015-8355-9 · Cited by 122
“Finally, supporting the hypothesis of synaptic dysfunction, several groups have recently reported that Ab 42 oligomers impair NMDA receptor function in vitro (Lacor et al. 2007; De Felice et al. 2007; Shankar et al. 2007; Snyder et al. 2005).”
Liu, R., Gao, M., Qiang, G., Zhang, T.-T., Lan, X., Ying, J., & Du, G.-H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.009 · Cited by 117
“Later evidence showed that the MDA receptor acted either as a selective substrate of A inding or as a mediator of A -triggered glutamate excito- oxicity, appearing as important factors to cause memory eficit in AD (Snyder et al., 2005).”
Backgroundc-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo
Sclip, A., Tozzi, A., Abaza, A., Cardinetti, D., Colombo, I., Calabresi, P., Salmona, M., Welker, E., & Borsello, T. (2014) · Cell Death & Disease · doi:10.1038/cddis.2013.559 · Cited by 106
Amyloid‐β oligomers impair fear conditioned memory in a calcineurin‐dependent fashion in mice
Dineley, K. T., Kayed, R., Neugebauer, V., Fu, Y., Zhang, W., Reese, L. C., & Taglialatela, G. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22445 · Cited by 106
“, 2009); the CaN inhibitor FK506 affects NMDA receptor trafficking at the synapse (Snyder et al., 2005) and blocks endocytosis of AMPA receptors induced by Ab oligomers, thus preventing synapses disruption (Zhao et al.”
Evidence of Aβ‐ and transgene‐dependent defects in ERK‐CREB signaling in Alzheimer’s models
Ma, Q., Harris‐White, M. E., Ubeda, O. J., Simmons, M., Beech, W., Lim, G. P., Teter, B., Frautschy, S. A., & Cole, G. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04869.x · Cited by 106
Shrivastava, A. N., Kowalewski, J. M., Renner, M., Bousset, L., Koulakoff, A., Melki, R., Giaume, C., & Triller, A. (2013) · Glia · doi:10.1002/glia.22548 · Cited by 105
Braithwaite, S. P., Adkisson, M., Leung, J., Nava, A., Masterson, B., Urfer, R., Oksenberg, D., & Nikolich, K. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04837.x · Cited by 105
“A recent study has further linked STEP to the regulated internalization of NMDARs (Snyder et al., 2005).”
BackgroundPreciados, M., Yoo, C., & Roy, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122086 · Cited by 113
Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease
Popugaeva, E., Pchitskaya, E., & Bezprozvanny, I. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7506 · Cited by 104
Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology
Esteras, N., & Abramov, A. Y. (2020) · Cells · doi:10.3390/cells9092135 · Cited by 103
Neurochemical basis for symptomatic treatment of Alzheimer's disease
Francis, P. T., Ramírez, M. J., & Lai, M. K. P. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.010 · Cited by 115
“…an effect of symptoms, particularly cognition, if as has been widely reported oligomers of the peptide acutely impair long-term potentiation and learning and memory via actions on both cholinergic and glutamatergic neurotransmission (Li et al., 2009; Parri and Dineley, 2010; Snyder et al., 2005).”
Paul, S., Olausson, P., Venkitaramani, D. V., Ruchkina, I., Moran, T. D., Tronson, N. C., Mills, E., Hakim, S., Salter, M. W., Taylor, J. R., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.005 · Cited by 110
“, 2002), and participate in NMDAR internalization in hippocampal cultures and tissue (Snyder et al., 2005).”
BackgroundSelf-citationFani, G., Mannini, B., Vecchi, G., Cascella, R., Cecchi, C., Dobson, C. M., Vendruscolo, M., & Chiti, F. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00811 · Cited by 101
Amyloid β peptide adversely affects spine number and motility in hippocampal neurons
Shrestha, B. R., Vitolo, O. V., Joshi, P., Lordkipanidze, T., Shelanski, M., & Dunaevsky, A. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.07.011 · Cited by 88
“, 2002), perhaps due to altered trafficking of glutamatergic receptors (Almeida et al., 2005; Roselli et al., 2005; Snyder et al., 2005).”
BackgroundSelective induction of calcineurin activity and signaling by oligomeric amyloid beta
Reese, L. C., Zhang, W., Dineley, K. T., Kayed, R., & Taglialatela, G. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00434.x · Cited by 103
“Either directly or indirectly (through activation of PP-1), CaN promotes dephosphorylative inactivation of CREB, a transcription factor reportedly essential for LTP, synaptic plasticity, and memory function (Bito et al., 1996; Lin et al., 2003; Snyder et al., 2005).”
Miñano-Molina, A. J., España, J., Martín, E., Barneda-Zahonero, B., Fadó, R., Solé, M., Trullás, R., Saura, C. A., & Rodríguez-Alvarez, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227504 · Cited by 103
Synapse formation on adult‐born hippocampal neurons
Toni, N., & Sultan, S. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07604.x · Cited by 102
“Indeed, amyloid beta reduces NMDA receptor expression (Snyder et al., 2005) and spine formation (Spires et al.”
Unsupervised excitation: GABAergic dysfunctions in Alzheimer’s disease
Ambrad Giovannetti, E., & Fuhrmann, M. (2019) · Brain Research · doi:10.1016/j.brainres.2018.11.042 · Cited by 102
Izzo, N. J., Yuede, C. M., LaBarbera, K. M., Limegrover, C. S., Rehak, C., Yurko, R., Waybright, L., Look, G., Rishton, G., Safferstein, H., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12302 · Cited by 95
Wang, H.-Y., Stucky, A., Liu, J., Shen, C., Trocme-Thibierge, C., & Morain, P. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.6088-08.2009 · Cited by 102
“…NMDAR function we show after removal of A 42 from 7nAChRs, along with the prevention by -BTX of A -induced NMDAR-NR1 subunit internalization (Snyder et al., 2005) and the milder cognitive deficit induced by A after eliminating 7nAChRs (Dziewczapolski et al., 2009), all indicate that 7nAChR…”
Influential
Metadata
- Authors
- Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., & Greengard, P.
- Affiliations
- Rockefeller University (US)
- Hospital for Sick Children (CA)
- Yale University (US)
- Cornell University (US)
- Corresponding author
- Snyder, Eric M
- Venue
- Nature Neuroscience
- Published
- 2005-07-17
- Volume
- 8
- Issue
- 8
- Pages
- 1051-1058
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1980750700
- Cited by
- 1,561
- References
- 41
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 43 · 2023: 50 · 2022: 54 · 2021: 80 · 2020: 75 · 2019: 52 · 2018: 70 · 2017: 74 · 2016: 78 · 2015: 81 · 2014: 89 · 2013: 91 · 2012: 97
- FWCI
- 50.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (01527, 52711)
- National Institute on Aging (AG09464, P01AG009464)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, NMDA receptor trafficking, receptor internalization, Alzheimer's disease, glutamatergic neurotransmission, synaptic plasticity, gamma-secretase inhibitors, alpha7 nicotinic acetylcholine receptor, calcineurin, synaptic dysfunction, cortical neurons
- MeSH terms
- Alzheimer Disease, Animals, Cell Membrane, Cerebral Cortex, Disease Models, Animal, Electric Conductivity, Endocytosis, Enzyme Activation, Neurons, Nuclear Proteins, Peptide Fragments, Receptors, Nicotinic, Synapses, Signal Transduction, Trans-Activators, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Protein Tyrosine Phosphatases, Calcineurin, Protein Transport, CREB-Binding Protein, Mice, Protein Tyrosine Phosphatases, Non-Receptor, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.